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The aim of this study was to determine the gene- and microRNA-expression proﬁle contributing to epithelial to
mesenchymal transition in a rat model of experimental colitis. For this, inﬂammation was induced by injecting 2,4,6-
trinitrobenzene sulphonic acid to the colon of male Wistar rats. Samples were taken from both inﬂamed and uninﬂamed
regions of the same colon, total RNA was isolated, and the mRNA and microRNA expressions were monitored. We have
determined that the expression of genes responsible for inducing mesenchymal phenotype, such as Egr1, Fgf2, Fgf7, Jak2,
Notch2, Hif1α, Zeb2, Mmp9, Lox, and Vim, was all signiﬁcantly induced in the inﬂamed regions of the aﬀected colons
while the epithelial marker E-cadherin (Cdh1) was downregulated. In contrast, the expression of microRNAs miR-192,
miR-143, miR-375, miR-30a, miR-107, and miR-200b responsible for the regulation of the above mentioned genes was
signiﬁcantly downregulated in inﬂamed colon. Importantly, we detected moderate induction in the expression of ﬁve out
of six tested microRNAs in the uninﬂamed regions. In summary, we identiﬁed numerous interacting genes and
microRNAs with mutually exclusive expression pattern in inﬂamed regions of colitis-induced rats. These ﬁndings suggest
that—among others—an important step in the epithelial to mesenchymal transition in experimental colitis is the
dysregulated microRNA expression.
1. Introduction
Inﬂammatory bowel disease (IBD) is a chronic relapsing
disorder of the gastrointestinal tract. The two main clini-
cal appearances of IBD are ulcerative colitis (UC) and
Crohn’s disease (CD): both cause idiopathic, returning
inﬂammation along the digestive system, where inﬂamed
and uninﬂamed regions sporadically follow each other.
Primary symptoms of this lifelong disease are abdominal
pain, diarrhoea, and malabsorption which are signiﬁcantly
aﬀecting the quality of life. Chronic inﬂammation, the
main feature of IBD, is also a well-known factor in
cancer progression. In line with this, IBD signiﬁcantly
increases the probability of colorectal cancer [1, 2]. A
crucial step in cancer development and progression of
chronic inﬂammatory diseases is the epithelial to mesen-
chymal transition (EMT). During EMT cell-cell connec-
tions disintegrate, the expression of extracellular matrix
components, such as vimentin and metalloproteases,
increases and as a consequence cells migrate to the inter-
stitium. Under physiological conditions, EMT is an essen-
tial process of wound healing; however, in the absence of
proper control, motile cells move through the basal mem-
brane and cause inﬂammation [3, 4]. The progression of
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EMT is regulated by complex molecular mechanisms:
transcription factors, such as Snail, Twist, and Zeb,
suppress the expression of a well-known epithelial marker
E-cadherin (Cdh1). Subsequently, decreased expression of
Cdh1 leads to the failure of cell-cell connections; therefore,
mesenchymal phenotype emerges. In this process, interre-
lated signalling pathways, such as Notch and JAK-STAT
pathways, also promote the formation of the mesenchymal
phenotype [5–9].
Genes known to play role in EMT may be regulated by
small, noncoding microRNA (miRNA) molecules, which
are directly inﬂuencing the translation or degradation of
messenger RNAs (mRNAs) by binding to their 3′-UTRs.
miRNAs can also aﬀect epigenetic landscape through the
inhibition of DNA methyltransferase genes, thereby causing
global gene expression changes [10]. The involvement of
miRNAs, such as the miR-200 family members (miR-200a,
miR-200b, miR-200c, miR-141, and miR-429), regulating
EMT has been shown earlier; in addition, their dysregulated
expression was described in several oncologic conditions
[11, 12]. Furthermore, EMT-associated miRNA/mRNA
signatures of clear-cell renal cell carcinoma patients highly
correlated with clinical stages of cancer progression, which
imply the prognostic potential of combined miRNA/
mRNA expression proﬁling in diﬀerent EMT-related
diseases [13].
Understanding the molecular mechanisms inducing and
regulating EMT—such as transcriptional and posttranscrip-
tional modiﬁcations—upon chronic intestinal inﬂammation
are critical for understanding the exact pathomechanism of
ulcerative colitis and Crohn’s disease. In line with this, the
aim of this study was to determine the expression patterns
of EMT-related genes as well as miRNAs regulating these
genes in the inﬂamed and uninﬂamed colon regions of the
2,4,6-trinitrobenzene sulphonic acid- (TNBS-) induced rat
model of experimental colitis.
2. Materials and Methods
2.1. In Vivo Rat Model and Sample Collection.We used male
Wistar rats weighing 180–220 g. All rats had access to
water and food ad libitum, except overnight before induc-
tion of colitis. The animals were randomly divided into
two groups: the ﬁrst group served as control (n = 2;
vehicle-treated hence noncolitis induced) and the second
group was induced by 2,4,6-trinitrobenzene sulphonic acid
(TNBS) (n = 6; colitis-induced) based on the method
described by Morris et al. [14]. Brieﬂy, TNBS (10mg in
0.25ml of 50% ethanol, w/v) was intracolonically adminis-
tered in a volume of 0.25ml, via an 8 cm long plastic cath-
eter under transient ether anaesthesia. 72 hours after the
treatment, all animals were sacriﬁced and ~8 cm of distal
colons were removed, opened longitudinally, and gently
cleaned of fecal content using ice-cold physiological saline.
In the case of the control group, since noninﬂamed, sam-
ples were taken from random colon sections (Figure 1(a)).
In case of colitis-induced animals, samples were taken
from inﬂamed colon region as well as from nonadjacent
uninﬂamed region (Figure 1(b)). All samples were kept
in TRIzol reagent (Thermo Fisher) at −80°C.
2.2. Extraction of Total RNA and Reverse Transcription. Sam-
ples from the colon were homogenized in TRIzol reagent by
ULTRA-TURRAX T-18 (IKA) instrument as described pre-
viously [15]. 0,1ml of chloroform (Sigma-Aldrich) was
added to 0,3ml homogenized sample with vigorous vortex-
ing. Samples were centrifuged at 13000 rpm for 10 minutes.
Total RNA was than extracted from the upper aqueous phase
with RNeasy Plus Mini Kit (Qiagen) according to the manu-
facturer’s protocol. The quality and the quantity of the
extracted RNAs were determined by TapeStation (Agilent)
and Qubit ﬂuorometer (Thermo Fisher). The extracted total
RNA samples were only used if the RNA integrity number
(RIN) was greater than 7.
Reverse transcription was performed by two diﬀerent
kits, depending on the type of RNA to be reverse transcribed.
For mRNA detection, cDNA was synthesized using Super-
Script VILO Master Mix (Thermo Fisher) according to the
manufacturer’s instructions. Brieﬂy, at least 70 ng total
RNA was combined with 5X VILO ReactionMix, 10X Super-
Script Enzyme Mix, and nuclease-free water. The reaction
was incubated at 25°C for 10 minutes, then at 42°C for 60
minutes, and ﬁnally at 85°C for 5 minutes. For miRNA detec-
tion, TaqMan MicroRNA Reverse Transcription Kit
(Thermo Fisher) was used. Brieﬂy, at least 6 ng total RNA
per reaction was mixed with the following components:
100mM dNTPs, MultiScribe Reverse Transcriptase, 10X
(a) (b)
Figure 1: Representative images of noninduced (a) and colitis-induced (b) colons. Green box in (a) indicates control sampling; red and blue
boxes in (b) indicate sampling from colitis-induced inﬂamed and uninﬂamed regions, respectively.
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Reverse Transcription Buﬀer, RNase inhibitor, and nuclease-
free water. Revers transcription reactions were performed
under the following PCR conditions: 30 minutes at 16°C, 30
minutes at 42°C, and 5 minutes at 85°C.
2.3. Quantitative Real-Time PCR (QRT-PCR). miRNA or
mRNA expression was measured by real-time PCR using
the StepOne PCR Systems (Thermo Fisher). SybrGreen and
TaqMan technology-based quantitative real-time PCR was
used to quantify the relative abundance of the selected
mRNAs. For this, speciﬁc exon spanning primer sets were
used as listed in Table 1. As controls, we used reaction mix-
tures without cDNA. Brieﬂy, ampliﬁcation was carried out
in a total volume of 6μl, containing 1μl of cDNA, 3μl of
SYBR Select Master Mix (2×), 1,04μl nuclease-free water,
0,48μl of forward, and 0,48μl reverse primer. The QRT-
PCR reactions were performed under the following PCR
conditions: one cycle of 2 minutes at 50°C and 2 minutes
at 95°C, followed by 40 cycles of 15 sec each at 95°C, and
1 minute at 60°C. Detection of nonspeciﬁc ampliﬁcation
was carried out by melt curve analysis. TaqMan
technology-based reactions were performed in total volume
of 4μl, containing 1μl cDNA, 2μl of TaqMan Fast
Advanced Master Mix (2×), 0,2μl TaqMan Gene Expres-
sion Assay, and 0,8μl nuclease-free water. Thermal-cycling
conditions were as follows: one cycle of 2 minutes at 50°C
and 20 sec at 95°C and followed by 40 cycles of 1 sec at
95°C and 20 sec at 60°C. All of the measurements were per-
formed in duplicate with at least two biological replicates.
The ratio of each mRNA relative to the 18S rRNA (Thermo
Fisher assay number hs-99999901_s1) was calculated using
the 2−ΔΔCT method.
For measurement of miRNA expression levels, Taq-
Man Universal PCR Master Mix (Thermo Fisher) was
used according to the manufacturer’s instructions. Brieﬂy,
ampliﬁcation was carried out in a total volume of 15μl
containing the following components: 1μl miRNA speciﬁc
cDNA, 0,75μl TaqMan Small RNA Assay (20×), 7,52μl
TaqMan Universal PCR Master Mix (2×), and 5,73μl
nuclease-free water. Thermal-cycling conditions were as
follows: one cycle of 10 minutes at 95°C, 40 cycles of
15 sec at 95°C, and 1 minute at 60°C. The speciﬁc miRNA
assays were purchased from Thermo Scientiﬁc; assay num-
bers are shown in Table 2. The ratio of each miRNA rel-
ative to the endogenous U6 snRNA was calculated using
the 2−ΔΔCT method.
2.4. Statistical Analysis and Data Representation. Statistical
evaluations were performed using the IBM SPSS Statistics
program for Windows. Graphs were plotted with GraphPad
Prism 6 software. Quantitative data are presented as the
mean± SEM, and the signiﬁcance of diﬀerence between sets
of data was determined by one-way analysis of variance
(ANOVA) following LSD post hoc test; a p value of less than
0.05 was considered signiﬁcant.
3. Results and Discussion
In order to investigate whether EMT is involved in the
pathogenesis of chronic colon inﬂammation, we used
the 2,4,6-trinitrobenzene sulfonic acid- (TNBS-) induced
rat model of colitis, in which the inﬂammatory response
is due to the generation of transmural oxidative stress
and release of proinﬂammatory mediators [16, 17]. We
hypothesized that even though only marked regions of
the colon show severe inﬂammation (Figure 1(b)),
Table 1: SybrGreen primer sets used in QPCR experiments.
Gene Forward (5′-3′) Reverse (5′-3′)
Egr1 AACAACCCTACGAGCACCTG AAAGGGGTTCAGGCCACAAA
Fgf2 GCGACCCACACGTCAAACTA CCGTGACCGGTAAGTGTTGTA
Fgf7 TGTGGCAATCAAAGGGGTGG AAGGCCACGAACATTTCCCC
Jak2 AGTGTGCTACAGTGCTGGTC TTCCTTGTTGCCAGATCCCG
Mmp9 GCCGGGAACGTATCTGGAAA GGTTGTGGAAACTCACACGC
Notch2 AACTGCACCTCCTCACTTCG CTCCTCGTTGTTGCATCCCT
Vim CATGCGGCTGCGAGAAAAAT GGTCAAGACGTGCCAGAGAA
Zeb2 AAAGCAGTTCCCTTCTGCGA AGGAGCCCGAGTGTGAAAAG
Hif1α CTCATCCAAGGAGCCTTAACCT TAACGTTCCAATTCCTGCTGC
Lox AGGGCGGATGTCAGAGACTA CATCCAGCAGGTCGTAGTGG
Cdh1 CCACCAGATGACGATACCCG GAATCACTTCCGGTCTGGCA
Table 2: miRNA speciﬁc TaqMan microRNA assays.
miRNA Assay number
miR-125a 002198
miR-192 000491
miR-200b 002251
miR-375 000564
miR-30a 000417
miR-107 000443
miR-143 463509
U6 snRNA 001973
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proximal, phenotypically not inﬂamed regions may also
be aﬀected. Hence, we decided to take two samples from
the colons of the colitis-induced animals: one sample
corresponds to the severely inﬂamed region and the
other to noninﬂamed region, referred as inﬂamed and
uninﬂamed, respectively; the two regions are being sepa-
rated by at least 2 cm from each other (Figure 1(b)).
Subsequently, we determined the expression proﬁle of
selected genes and microRNAs related to EMT.
3.1. Induced Expression of Growth Factors at the Site of
Induced Colitis. Signalling pathways activating the formation
of motile mesenchymal cells are induced by growth
factors, such as the early growth response protein 1
(Egr1) and ﬁbroblast growth factors 2 and 7 (Fgf2, Fgf7)
[18, 19]. All three genes showed increased expression in
inﬂamed region of the colitis-induced colons as compared
to both controls and noninﬂamed regions (Figures 2(a)–
2(c)). It is known that miR-192 regulates the expression
of Egr1 and Fgf2, while miR-143 is a known inhibitor of
Fgf7 [20]. As compared to controls, both miRNAs are
slightly but not signiﬁcantly induced in uninﬂamed
regions and supressed in inﬂamed regions. When compar-
ing the expression in uninﬂamed versus inﬂamed regions,
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Figure 2: Opposing expression of growth factors and their regulating miRNAs at the site of colon inﬂammation. The relative gene expression
of growth factors Egr1 (a), Fgf2 (b), and Fgf7 (c) shows signiﬁcant upregulation in inﬂamed colons as compared to both control and
uninﬂamed colons of colitis-induced animals. In contrast, the expression pattern of both miR-192 (d) and miR-143 (e) shows slight
upregulation in uninﬂamed colons and a signiﬁcant downregulation in inﬂamed colons. Data are presented as the mean± SEM; the
signiﬁcance of diﬀerences between sets of data was determined by one-way analysis of variance (ANOVA) using SPSS Statistics; ∗p < 0 05.
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we detected signiﬁcant suppression in inﬂamed regions
(Figures 2(d) and 2(e)). The negative correlation between
the gene and microRNA expression suggests that the
increased mRNA levels of growth factors (Egr1, Fgf2,
and Fgf7) may be due to the downregulated expression
of their regulating microRNAs (miR-192, miR-143).
3.2. JAK/STAT and Notch Signalling Pathways Are
Activated upon Inﬂammation of the Colon. We next moni-
tored the expression proﬁle of key molecules belonging to
the JAK/STAT and Notch pathways that play important
roles in the regulation of expression of transcription factors
associated with EMT [6, 9]. We observed that both Janus
kinase 2 (Jak2) and Notch2 were upregulated in the
colitis-induced inﬂamed colon regions (Figures 3(a) and
3(b)). Ding et al. earlier demonstrated that miR-375
directly targets the Jak2 oncogene, thereby regulating
cancer cell proliferation [21]. In our model, the amount
of miR-375 was signiﬁcantly decreased in the inﬂamed
region, while elevated in the TNBS treated uninﬂamed sec-
tions (Figure 3(d)). When monitoring the expression of
miR-30a, the endogenous inhibitor of Notch2 expression
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Figure 3: Induced expression of genes regulating proliferation occurs due to decreased expression of miRNAs. The relative gene expression of
Jak2 (a), Notch2 (b), and Hif1α (c) shows signiﬁcant upregulation in inﬂamed colons as compared to both control and uninﬂamed colons of
colitis-induced animals. In contrast, the expression of miR-375 (d), miR-30a (e), and miR-107 (f) is signiﬁcantly downregulated in inﬂamed
colons. Data are presented as the mean± SEM; the signiﬁcance of diﬀerences between sets of data was determined by one-way analysis of
variance (ANOVA) using SPSS Statistics; ∗p < 0 05.
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[22], we again detected signiﬁcant decrease in inﬂamed
samples (Figure 3(e)).
Notch pathway is also induced by hypoxia; therefore, we
next examined the expression of a well-known marker of
hypoxia and oxidative stress, hypoxia induced factor 1 α
(Hif1α) [6]. mRNA level of Hif1α was again signiﬁcantly
induced in inﬂamed region of the colon (Figure 3(c)). In
contrast, the expression of miR-107, a common regulator
of Notch2 and Hif1α [23, 24], decreased in colitis-induced
samples (Figure 3(f)). These data suggest that the absence
of inhibition caused by decreased miRNA expression in
inﬂamed regions may shift cell proliferation balancing path-
ways towards EMT.
3.3. Cells Lose Epithelial Nature at the Site of Colon
Inﬂammation. Transcription factors involved in the pro-
gression of EMT are, among others, Snail, Twist, and Zeb
[25]. Zeb2 has a fundamental role in the expressional inhibi-
tion of E-cadherin coding gene, Cdh1 [26]. This process is
under the control of a well described regulatory feedback
loop between Zeb2 and miR-200b; importantly, Zeb2 and
miR-200b can also inhibit each other [27]. To prove if EMT
was indeed induced after colitis induction, we ﬁrst deter-
mined the expression of epithelial marker Cdh1 and its regu-
lator Zeb2. While the mRNA level of Zeb2 was markedly
upregulated at the site of inﬂammation, Cdh1 was signiﬁ-
cantly downregulated (Figures 4(a) and 4(b)). The expression
of miR-200b also inversely correlated with the expression of
Zeb2, being markedly downregulated in inﬂamed regions
(Figure 4(c)). It is important to note that miR-192, also
known to regulate the expression of Zeb2 [28], exhibits sim-
ilar expression proﬁle as miR-200b (Figure 2(d)). These data
show that the expression of Zeb2 is de-repressed at the site of
colonic inﬂammation due to the decreased expression of its
microRNA regulators miR-200b and miR-192. Increased
Zeb2 expression, in turn, downregulates epithelial marker
Cdh1 expression, and as a result, cells lose their connections
as well as apical-basal polarity which all act in favour of epi-
thelial to mesenchymal transition.
3.4. Colon Inﬂammation Is Marked by Gain of Mesenchymal
Characteristics. A well-known marker of EMT is the
expression of the mesenchymal marker vimentin (Vim)
[29]. Furthermore, a prerequisite of cell invasion is the rear-
rangement of microenvironment by extracellular enzymes,
such as matrix metalloproteinase 9 (Mmp9) and lysyl oxidase
(Lox) [8]. We have determined that Mmp9, Lox, and Vim all
show signiﬁcantly induced expression in inﬂamed colon
(Figures 5(a)–5(c)) pointing toward gain of mesenchymal
phenotype at the site of colon inﬂammation. Again, miR-
125a, miR-30a, and miR-200b regulating Mmp9, Lox, and
Vim, respectively [30–32], are all downregulated in inﬂamed
region as compared to uninﬂamed colon (Figures 3(e), 4(c),
and 5(d)). Altogether, these expressional changes conﬁrm
that epithelial to mesenchymal transition indeed takes place
in colitis induced rats.
4. Conclusion
Our present study demonstrates that the epithelial to mesen-
chymal transition is activated during colitis induction in rats.
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Figure 4: Induced expression of Zeb2 in inﬂamed colon downregulates the expression of its targets Cdh1 and miR-200b. The relative gene
expression of Zeb2 (a) is signiﬁcantly induced in inﬂamed colons as compared to both control and uninﬂamed colons of colitis-induced
animals. In contrast, epithelial markers Cdh1 (b) and miR-200b (c) are both signiﬁcantly downregulated in inﬂamed colons of
colitis-induced animals. Data are presented as the mean± SEM; the signiﬁcance of diﬀerences between sets of data was determined
by one-way analysis of variance (ANOVA) using SPSS Statistics; ∗p < 0 05.
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The presented data indicate that, among others, the activa-
tion takes place due to the opposed expression proﬁle of
genes and their regulating microRNAs at the site of
inﬂammation (Figure 6); while the expression of all tested
mesenchymal markers (Egr1, Fgf2, Fgf7, Jak2, Notch2,
Hif1α, Zeb2, Mmp9, Lox, and Vim) was signiﬁcantly
induced, microRNAs regulating their expression decreased
(miR-192, miR-143, miR-375, miR-30a, miR-107, miR-
200b, and miR-125a). In parallel, the expression of E-cad-
herin, a speciﬁc marker of epithelial cells, also decreased
further supporting the loss of epithelial phenotype at the
site of inﬂammation. These ﬁndings shed light onto a
microRNA-mediated regulation inﬂuencing epithelial to
mesenchymal transition in experimental colitis.
5. Perspectives
The number of miRNAs shown to be downregulated in IBD
is increasing. Elevating the level of these cellular miRNAs
using miRNA mimics holds the potential to become a true
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Figure 5: The expression of mesenchymal markers Mmp9, Lox, and Vim is upregulated at the site of colon inﬂammation. The relative gene
expression of Mmp9 (a), Lox (b), and Vim (c) is signiﬁcantly induced in inﬂamed colons as compared to both control and uninﬂamed colons
of colitis-induced animals. Conversely, mir-125a (d) shows slight but not signiﬁcant downregulation in both uninﬂamed and inﬂamed colons
(p = 0 285 and p = 0 135, resp.). Data are presented as the mean± SEM; the signiﬁcance of diﬀerences between sets of data was determined by
one-way analysis of variance (ANOVA) using SPSS Statistics; ∗p < 0 05.
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alternative for therapeutic restoration of physiological path-
ways lost in IBD. Since miRNAs target multiple genes, resto-
ration of downregulated miRNAs has the potential to have a
greater therapeutic eﬀect than drugs with a single protein
target [33]. Indeed, recent successful phase IIa studies of
miRNA therapy in humans are all in favour of miRNAs being
potential therapeutic targets in IBD.
Emerging data also supports the involvement of another
class of noncoding RNAs, the long noncoding RNAs, in the
epithelial-to-mesenchymal transition. It has recently been
shown that HOTAIR (HOX Transcript Antisense Intergenic
RNA) mediates a physical interaction between Snail and
EZH2 (Enhancer of zeste homolog 2) and thereby inﬂuences
EMT [34]. In addition, multiple lncRNAs are diﬀerentially
expressed in IBD and are regulating cellular physiology
[35]. Whether lncRNAs may be potential therapeutic targets
in IBD remains to be determined.
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